SG11201401770YA - Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition - Google Patents
Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery compositionInfo
- Publication number
- SG11201401770YA SG11201401770YA SG11201401770YA SG11201401770YA SG11201401770YA SG 11201401770Y A SG11201401770Y A SG 11201401770YA SG 11201401770Y A SG11201401770Y A SG 11201401770YA SG 11201401770Y A SG11201401770Y A SG 11201401770YA SG 11201401770Y A SG11201401770Y A SG 11201401770YA
- Authority
- SG
- Singapore
- Prior art keywords
- delivery
- drug
- manufacturing
- composition
- polymeric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/307,474 US9474715B2 (en) | 2011-11-30 | 2011-11-30 | Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
| PCT/EP2012/073983 WO2013079605A2 (en) | 2011-11-30 | 2012-11-29 | Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201401770YA true SG11201401770YA (en) | 2014-09-26 |
Family
ID=47278823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401770YA SG11201401770YA (en) | 2011-11-30 | 2012-11-29 | Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9474715B2 (en) |
| EP (1) | EP2785330B1 (en) |
| JP (1) | JP2015502354A (en) |
| KR (1) | KR20140097541A (en) |
| CN (1) | CN104105480A (en) |
| AU (1) | AU2012343854A1 (en) |
| BR (1) | BR112014011609A2 (en) |
| CA (1) | CA2856794A1 (en) |
| ES (1) | ES2637379T3 (en) |
| RU (1) | RU2014126347A (en) |
| SG (1) | SG11201401770YA (en) |
| WO (1) | WO2013079605A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170290775A1 (en) * | 2014-10-07 | 2017-10-12 | Therakine Bio Delivery GmbH | Micronized delivery material and methods for manufacturing thereof |
| CN107106641B (en) | 2014-10-31 | 2021-12-21 | 葛兰素史密斯克莱知识产权发展有限公司 | Powder formulation |
| GB201500430D0 (en) | 2015-01-12 | 2015-02-25 | Univ Birmingham | Dressing |
| BR112020001261A2 (en) * | 2017-07-25 | 2020-07-21 | PK Med SAS | drug delivery composition |
| EP3675818B1 (en) * | 2017-10-12 | 2023-06-07 | SolyPlus GmbH | Processing method for biopolymers using solvent combinations |
| US20200316208A1 (en) * | 2017-10-12 | 2020-10-08 | Solyplus Berlin Gmbh | Mechanical processing of biopolymers |
| CN109529116B (en) * | 2019-01-29 | 2019-12-31 | 中国海洋大学 | NS-GAM gene active scaffold for treating scald and preparation method thereof |
| EP3811982A1 (en) * | 2019-10-25 | 2021-04-28 | Université de Strasbourg | Protein-based biomaterial with viscoelastic behaviour, process for obtaining it and uses thereof |
| CN115397480A (en) * | 2019-12-06 | 2022-11-25 | 广州倍绣生物技术有限公司 | Flowable fibrinogen thrombin paste |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1540979A (en) | 1923-04-11 | 1925-06-09 | Swift & Co | Machine for testing jelly strength of glues, gelatins, and the like |
| US5876754A (en) | 1992-01-17 | 1999-03-02 | Alfatec-Pharma Gmbh | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
| JPH06218028A (en) * | 1992-10-02 | 1994-08-09 | Eisai Co Ltd | Method and apparatus for molding wet-processed tablet, and the wet-processed tablet |
| ATE234855T1 (en) * | 1993-09-20 | 2003-04-15 | Anadis Ltd | METHOD FOR PRODUCING IMMUNOGLOBULINS FROM COLOSTRUM AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS |
| US5674495A (en) | 1995-02-27 | 1997-10-07 | Purdue Research Foundation | Alginate-based vaccine compositions |
| FI103207B (en) | 1996-08-27 | 1999-05-14 | Sune Backlund | Immobilized enzyme containing gel |
| IT1297461B1 (en) | 1997-10-29 | 1999-12-17 | Ciocca Maurizio | PREPARATION OF CONTROLLED RELEASE TABLETS BASED ON COMPLEXES BETWEEN CARRAGENANO AND SOLUBLE BASIC DRUGS |
| CA2378486A1 (en) * | 1999-08-05 | 2001-02-15 | Takashi Kurasawa | Osteogenesis promoter sustained-release paste |
| AU4724401A (en) * | 2000-02-28 | 2001-09-12 | Genesegues Inc | Nanocapsule encapsulation system and method |
| US7141555B2 (en) | 2000-12-19 | 2006-11-28 | Cephalon, Inc. | Modafinil compound and cyclodextrin mixtures |
| AUPR272901A0 (en) | 2001-01-25 | 2001-02-22 | Gainful Plan Limited | Method of preparing biological materials and preparations produced using same |
| US20070059336A1 (en) | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
| CN103082026A (en) | 2004-08-19 | 2013-05-08 | 帝斯曼知识产权资产管理有限公司 | Novel compositions of fat-soluble substances |
| WO2006057859A1 (en) | 2004-11-24 | 2006-06-01 | Therakine Corporation | An implant for intraocular drug delivery |
| CN101489569A (en) | 2006-06-12 | 2009-07-22 | 席拉坎有限责任公司 | Topical treatment for diseases of eye surface |
| US8039010B2 (en) | 2006-11-03 | 2011-10-18 | Allergan, Inc. | Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| EP2393476B1 (en) | 2009-02-04 | 2016-01-13 | DSM IP Assets B.V. | Resveratrol compositions |
-
2011
- 2011-11-30 US US13/307,474 patent/US9474715B2/en active Active
-
2012
- 2012-11-29 KR KR1020147018156A patent/KR20140097541A/en not_active Application Discontinuation
- 2012-11-29 AU AU2012343854A patent/AU2012343854A1/en not_active Abandoned
- 2012-11-29 ES ES12794951.9T patent/ES2637379T3/en active Active
- 2012-11-29 CA CA2856794A patent/CA2856794A1/en not_active Abandoned
- 2012-11-29 RU RU2014126347A patent/RU2014126347A/en not_active Application Discontinuation
- 2012-11-29 JP JP2014543893A patent/JP2015502354A/en active Pending
- 2012-11-29 SG SG11201401770YA patent/SG11201401770YA/en unknown
- 2012-11-29 EP EP12794951.9A patent/EP2785330B1/en active Active
- 2012-11-29 CN CN201280058719.XA patent/CN104105480A/en active Pending
- 2012-11-29 BR BR112014011609A patent/BR112014011609A2/en not_active Application Discontinuation
- 2012-11-29 WO PCT/EP2012/073983 patent/WO2013079605A2/en active Application Filing
-
2016
- 2016-09-27 US US15/277,395 patent/US20170095419A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015502354A (en) | 2015-01-22 |
| US9474715B2 (en) | 2016-10-25 |
| BR112014011609A2 (en) | 2017-05-30 |
| CN104105480A (en) | 2014-10-15 |
| EP2785330B1 (en) | 2017-03-29 |
| WO2013079605A2 (en) | 2013-06-06 |
| KR20140097541A (en) | 2014-08-06 |
| CA2856794A1 (en) | 2013-06-06 |
| ES2637379T3 (en) | 2017-10-13 |
| US20130136774A1 (en) | 2013-05-30 |
| EP2785330A2 (en) | 2014-10-08 |
| AU2012343854A1 (en) | 2014-05-08 |
| RU2014126347A (en) | 2016-01-27 |
| WO2013079605A3 (en) | 2013-08-29 |
| US20170095419A1 (en) | 2017-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201401765TA (en) | Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition | |
| SG11201401770YA (en) | Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition | |
| HK1187654A1 (en) | Antimicrobial substance, method for producing same, and antimicrobial material | |
| EP2672539A4 (en) | Polymer piezoelectric material, and manufacturing method thereof | |
| EP2805734A4 (en) | Antimicrobial wound-covering material and method for manufacturing same | |
| EP2662910A4 (en) | Polymeric piezoelectric material and method for manufacturing same | |
| EP2660262A4 (en) | Method for manufacturing resin for urethane-based optical material, resin composition for same, and optical material manufactured thereby | |
| EP2700399A4 (en) | Drug delivery particles and method for producing same | |
| EP2771043A4 (en) | Methods for drug delivery | |
| EP2691126A4 (en) | Device and method for intraocular drug delivery | |
| EP2874209A4 (en) | Method for manufacturing coated active material | |
| EP2702103A4 (en) | A blend composition, flexible tubing material and method of making the blend | |
| EP2710994A4 (en) | Dental material, dental material composition, dental repair material, and cured product | |
| EP2765996A4 (en) | Nanoparticles for controlling bleeding and drug delivery | |
| EP2835373A4 (en) | Epoxy compound having alkoxysilyl group, composition and hardened material comprising same, use for same, and production method for epoxy compound having alkoxysilyl group | |
| EP2760069A4 (en) | Electrode material, electrode and electrode material manufacturing method | |
| HUE062316T2 (en) | Drug delivery technology | |
| IL230998A0 (en) | Drug delivery system and method of manufacturing thereof | |
| EP2679608A4 (en) | High-concentration polymer polyol and method for manufacturing same | |
| EP2718097A4 (en) | Material composition, laminate tube and method for manufacture thereof | |
| SG11201402185YA (en) | Construction material mixture, a method for producing same, and use thereof | |
| HRP20181316T1 (en) | Drug delivery technology | |
| IL254182A0 (en) | Drug delivery system and method of manufacturing thereof | |
| EP2634149A4 (en) | Powder material, method for manufacturing communication device, and communication device | |
| EP2687218A4 (en) | Pharmaceutical composition and manufacturing method therefor |